In severe asthma with an eosinophilic phenotype, depemokimab improved exacerbations, but not quality of life, at 52 wk

被引：0
|
作者：
McDonald, Christine F. [1 ,2 ]
机构：
[1] Austin Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
ANNALS OF INTERNAL MEDICINE | 2025年 / 178卷 / 01期
关键词：
D O I：
10.7326/ANNALS-24-03437-JC
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical Impact Ratings GIM/FP/GP: Allerg & Immunol: Pulmonology:
引用
收藏
页码：JC8 / JC8
页数：1
相关论文
共 50 条
  • [41] Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
    Sakai, Chio
    Matsuyama, Masashi
    Nakajima, Masayuki
    Matsumura, Sosuke
    Nonaka, Mizu
    Arai, Naoki
    Kuramoto, Kenya
    Yoshida, Kazufumi
    Morishima, Yuko
    Muratani, Masafumi
    Hizawa, Nobuyuki
    ALLERGOLOGY INTERNATIONAL, 2024, 73 (03) : 473 - 476
  • [42] Prevalence of the eosinophilic phenotype among severe asthma patients in Brazil: the BRAEOS study
    Athanazio, Rodrigo
    Stelmach, Rafael
    Antila, Martti
    Souza-Machado, Adelmir
    Arruda, L. Karla
    Neto, Alcindo Cerci
    Serpa, Faradiba Sarquis
    Blanco, Daniela Cavalet
    Lima, Marina
    Bianchi Junior, Pedro
    Penha, Marcio
    Rabahi, Marcelo Fouad
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2022, 48 (03) : e20210367
  • [43] Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life
    Chipps, Bradley E.
    Haselkorn, Tmirah
    Rosen, Karin
    Mink, David R.
    Trzaskoma, Benjamin L.
    Luskin, Allan T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (01): : 169 - +
  • [44] Determinants of cough and caregivers' quality of life in pediatric asthma exacerbations
    Teoh, Laurel
    Chatfield, Mark D.
    Acworth, Jason P.
    McCallum, Gabrielle B.
    Chang, Anne B.
    PEDIATRIC PULMONOLOGY, 2021, 56 (02) : 371 - 377
  • [45] The Influence of Asthma Exacerbations on Health-Related Quality of Life
    Mroczek, B.
    Kurpas, D.
    Urban, M.
    Sitko, Z.
    Grodzki, T.
    VENTILATORY DISORDERS, 2015, 873 : 65 - 77
  • [46] A Meta-Analysis Of Exacerbations Requiring Hospitalization From Studies Of Mepolizumab In Severe Eosinophilic Asthma
    Pavord, I.
    Ortega, H.
    Keene, O.
    Mayer, B.
    Yancey, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [47] Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with
    Muemmler, Carlo
    Mertsch, Pontus
    Barnikel, Michaela
    Haubner, Frank
    Schoenermarck, Ulf
    Grabmaier, Ulrich
    Schulze-Koops, Hendrik
    Behr, Juergen
    Kneidinger, Nikolaus
    Milger, Katrin
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 557 - 572
  • [48] Benralizumab continues to improve quality of life after 6 months of treatment in Canadians with severe eosinophilic asthma
    Penz, E.
    Kayaniyil, S.
    Lancaster, B.
    Francoeur, B.
    Lee, J. K.
    Mallet, M.
    Tourin, O.
    Ramesh, W.
    Mahdavian, M.
    Walker, B. L.
    Belak, Z.
    Thawer, A.
    Dhawan, V
    Mbuagbaw, L.
    Noorduyn, S. G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [49] Improved small airway function by benralizumab in patients with severe eosinophilic asthma
    Badal, Tanya
    Reed, Nicola
    Seccombe, Leigh M.
    Cottee, Alice M.
    Thamrin, Cindy
    King, Gregory G.
    Peters, Matthew J.
    Farah, Claude S.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype
    Pelaia, Corrado
    Crimi, Claudia
    Pelaia, Girolamo
    Nolasco, Santi
    Campisi, Raffaele
    Heffler, Enrico
    Valenti, Giuseppe
    Crimi, Nunzio
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (07): : 780 - 788
12345